Hyaluronic Acid Molecular Weight: Why It Matters in Serum Formulation

What Molecular Weight Means for Hyaluronic Acid

Hyaluronic acid is a linear polysaccharide — a glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine linked by alternating β-1,4 and β-1,3 glycosidic bonds. The number of these repeating units in a single polymer chain determines the molecule's molecular weight, typically expressed in kilodaltons (kDa). In human tissue, endogenous HA exists predominantly in the high-molecular-weight range (1,000–4,000 kDa), where its viscoelastic and space-filling properties are essential for the structural integrity of the dermis, the lubrication of synovial joints, and the regulation of cellular hydration in connective tissue. As HA is degraded enzymatically by hyaluronidase or through oxidative fragmentation in ageing skin, the resulting low-molecular-weight fragments take on distinct biological signalling roles — including pro-inflammatory and wound-healing activity — mediated through CD44 and Toll-like receptor interactions that differ fundamentally from those of the intact parent molecule.

In the cosmetics industry, molecular weight grades are produced either by selective enzymatic degradation of native HMW-HA, by acid hydrolysis, or by fermentation-controlled biosynthesis. The cosmetic-grade sodium hyaluronate most formulators use sits in the 1,000–1,500 kDa range, which is appropriate for surface humectancy but does not deliver the sub-surface penetration that has driven demand for lower molecular weight grades in premium cosmetics and personal care product development. Understanding which molecular weight range you are purchasing — and verifying it via the supplier's certificate of analysis — is the first technical discipline required for any HA serum formulation project.

HMW vs LMW Hyaluronic Acid: How Molecular Weight Governs Skin Behaviour

The performance difference between high molecular weight and low molecular weight hyaluronic acid at the skin level is not a matter of marketing differentiation — it is a well-documented consequence of polymer physics and receptor biology. High molecular weight HA (HMW-HA), in the range of 1,000–4,000 kDa, is too large to penetrate the intact stratum corneum through passive diffusion. Its functional contribution in a topical cosmetic is surface-level: it forms a continuous, flexible, negatively charged hydrogel film on the skin surface that physically impedes transepidermal water loss (TEWL) by restricting evaporative flux through the stratum corneum. This occlusive-humectant mechanism delivers immediate and measurable improvements in surface hydration, skin smoothness, and the visual plumping of superficial fine lines — effects that are detectable by corneometry and optical profilometry within minutes of application.

Low molecular weight HA (LMW-HA), typically in the 5–300 kDa range, can penetrate into the upper layers of the stratum corneum due to its smaller hydrodynamic radius and reduced steric hindrance at the lipid bilayer surfaces. Fractions below approximately 20 kDa, sometimes referred to as oligo-hyaluronic acid or hydrolysed sodium hyaluronate, have been shown in confocal microscopy studies to reach the viable epidermis, where they interact with CD44 receptors on keratinocytes. This receptor engagement stimulates keratinocyte proliferation, differentiation, and lipid synthesis — processes that cumulatively support barrier repair and the restoration of the stratum corneum's lamellar lipid architecture. These are genuinely distinct biological effects from surface film formation, and they underpin the scientific rationale for using LMW-HA at meaningful concentrations alongside a HMW surface-binding fraction in well-engineered serums.

One nuance that product developers must understand is that the CD44-mediated biological activity of LMW-HA fragments is not uniform across the molecular weight range. Research published in journals including Acta Biomaterialia has demonstrated that fragments in the 4–20 kDa range specifically elicit pro-inflammatory signalling in injured tissue — a wound-healing response that is appropriate in regenerative medicine but may be undesirable in daily-use cosmetic formulations applied to healthy skin. Fractions above 50 kDa and the very large HMW forms, in contrast, appear to suppress inflammatory responses. For cosmetic formulation consultants developing sensitive-skin products, this distinction makes the 50–300 kDa mid-range a pragmatic target — delivering meaningful stratum corneum penetration without triggering the inflammatory receptor pathways associated with the lowest molecular weight oligosaccharide fractions.

Commercial Grades and Specifications: Navigating the Supplier Landscape

The commercial hyaluronic acid raw material market presents formulators with a bewildering range of grade descriptors — ultra-high, high, medium, low, micro, nano, oligo — that are used inconsistently across different suppliers and are not defined by any single international standard. This lack of harmonised nomenclature creates a practical risk for product developers: two raw materials labelled "low molecular weight hyaluronic acid" from different suppliers may have meaningfully different actual molecular weight distributions, with correspondingly different functional behaviour in the finished formula. The table below provides a practical reference framework based on the ranges most commonly cited in peer-reviewed literature and major supplier technical documentation, cross-referenced against expected functional behaviour at each tier.

When specifying raw materials, formulators working on clinically positioned serums should request SEC-MALS or GPC molecular weight distribution data — not just viscosity ranges — from suppliers, as viscosity measurements conflate concentration effects with molecular weight effects and can mask broad polydispersity in the supplied material. The weight-average molecular weight (Mw) and the polydispersity index (PDI, the ratio of Mw to Mn) together describe the actual molecular weight distribution of the material and enable meaningful comparison across suppliers. Consistent PDI values across production batches also matter for scale-up: high polydispersity in a low-MW HA raw material can result in batch-to-batch variability in both formulation viscosity and the proportion of the biologically active oligomeric fraction.

Serum Formulation Strategy: Concentration, Viscosity, and Carrier Phase Design

The formulation strategy for a hyaluronic acid serum must balance four competing variables simultaneously: the desired in-use skin feel (which is directly governed by total HA concentration and the molecular weight distribution of the blend), the target functional performance (surface humectancy versus sub-surface penetration versus receptor-mediated activity), the stability of the HA under the pH and temperature conditions of the formulation process, and the cost-to-performance ratio of the raw material selection. High molecular weight grades are less expensive per gram and more readily available, making them the natural base humectant in high-volume formulations. Lower molecular weight and hydrolysed grades are more technically specialised and command a significant price premium, so their inclusion should be driven by a clear functional rationale, not marketing vocabulary alone.

The carrier phase design is equally consequential. Pure aqueous serums maximise HA hydration but offer no occlusive protection to the humectant film once applied — in dry climates, this means the HA draws moisture upward from the epidermis rather than inward from the air, reversing the intended moisturisation direction. Incorporating a light emollient component — cyclopentasiloxane, squalane, C12-15 alkyl benzoate, or propanediol — in a clear micro-emulsion format addresses this by providing partial occlusion without disrupting the lightweight serum aesthetic. As detailed in the emulsion science guide for cosmetic formulators, even small quantities of a dispersed oil phase (2–5%) substantially improve the moisturisation durability of HA-rich serums in low-humidity application environments.

Thickener selection interacts strongly with HA molecular weight in determining final product viscosity. Carbomer and cross-linked acrylate polymers build viscosity independently of HA concentration and can be used to achieve the target serum consistency regardless of the HA molecular weight chosen — which is important when switching from a high-viscosity HMW grade to a low-viscosity LMW grade without reformulating the whole vehicle. Alternatively, relying on HMW-HA itself as the sole viscosity builder keeps the ingredient list short and maximises the HA concentration available for functional contribution, but constrains the formulator to the HMW grade's native viscosity curve. For multi-weight HA serums where LMW grades contribute a significant portion of the total HA, secondary thickening from a carbomer, hydroxyethylcellulose, or xanthan gum is typically required to achieve commercially acceptable serum consistency.

Stability, pH Management, and Degradation Risks in HA Serums

Hyaluronic acid stability in finished cosmetic formulations is governed primarily by pH and temperature, and failures in either parameter during processing or storage can silently eliminate the functional molecular weight distinction that justified the formulation strategy in the first place. HA undergoes acid-catalysed hydrolysis of its glycosidic bonds at pH below 4.0 — a rate that increases sharply below pH 3.5 and can reduce a 1,500 kDa HMW-HA to oligomeric fragments within weeks at pH 3.0 and 40 °C storage conditions. This is the most common and most damaging formulation error for HA serums designed to be combined with vitamin C (ascorbic acid), which performs best at pH 2.5–3.5 — a direct conflict with HA stability requirements. Formulators attempting to deliver both actives in a single product must either use a stabilised vitamin C derivative (ascorbyl glucoside, sodium ascorbyl phosphate, or 3-O-ethyl ascorbic acid) that functions at pH 5.0–6.0, or accept that the HMW-HA in such a low-pH formula will degrade progressively during the product's shelf life.

Alkaline conditions above pH 8.0 accelerate a different degradation pathway — base-catalysed beta-elimination and saponification of the ester-like bonds in the polysaccharide backbone — though this is less commonly encountered in cosmetic serum formulations. Thermal degradation is the third major stability risk: HA solutions exposed to temperatures above 60 °C during processing undergo irreversible molecular weight reduction through chain scission and oxidative radical reactions. High-molecular-weight grades are particularly susceptible to shear-induced degradation during high-speed mixing — a counter-intuitive failure mode where aggressive mechanical processing of a premium HMW-HA grade effectively converts it to a lower-weight fraction, negating the specification advantage over cheaper lower-MW alternatives. Standard guidance from major HA suppliers including fermentation-grade HA producers recommends dissolving HMW HA in cold to ambient-temperature water with low-shear mixing, never above 40 °C, and maintaining pH between 5.5 and 7.0 throughout all processing steps.

Preservative system compatibility is an additional stability consideration that is often overlooked. HA is not inherently susceptible to microbial attack — it is a non-nitrogenous polysaccharide with no protein content — but aqueous HA serums at neutral pH represent excellent culture media for bacteria and yeast, making adequate broad-spectrum preservation essential. Chelating agents used as preservative boosters — particularly disodium EDTA — do not directly affect HA chemistry, but formulators adding copper peptides or other metal-coordination actives alongside HA must ensure the chelating agent does not sequester the metal cofactor before it reaches the skin, as discussed in more detail in our guide to anti-aging peptide formulation strategy.

Multi-Weight Layering: Building a Clinically Differentiated HA Serum Architecture

The most sophisticated commercial approach to hyaluronic acid serum formulation uses multiple molecular weight fractions — typically two to four grades — combined in a single formula or delivered as a layered system. This multi-weight architecture is designed to address the full depth profile of the skin simultaneously: HMW-HA at the surface for occlusion and immediate sensory plumping; medium-MW HA in the upper stratum corneum for gradient humectancy; LMW-HA in the mid-to-deep stratum corneum for CD44-mediated barrier support; and oligo-HA at the viable epidermal boundary for receptor signalling and keratinocyte stimulation. Each fraction contributes to a different layer of the moisturisation mechanism, creating a product whose clinical performance profile is demonstrably richer than a single-fraction high-MW HA serum — and that justifies a premium price point through differentiated mechanism, not just ingredient quantity.

From a formulation standpoint, multi-weight HA systems require careful optimisation of the total HA concentration and the individual grade ratios to avoid the combined tackiness of multiple HA grades competing for the same water at the skin surface. The sensory profile of multi-weight serums is typically described by trained assessors as "initially plumping, then smoothing, then fast-absorbing" — a texture trajectory that distinguishes them from the sustained tackiness of high-concentration single-grade HMW serums. Achieving this profile requires the higher-MW fractions to be present at a lower relative concentration than their single-grade equivalent, compensated by the synergistic humectancy contribution of the penetrating LMW fractions. Formulation development for multi-weight serums is inherently iterative, and partnering with experienced cosmetic product development consultants who have access to sensory panel infrastructure and corneometry measurement capabilities accelerates time-to-launch significantly compared to purely laboratory-led development.

Regulatory positioning of multi-weight HA serums also benefits from a nuanced understanding of the molecular weight-to-claim relationship. Claims attributing visible hydration improvement to HMW surface film formation are straightforward to substantiate via standard corneometry studies. Claims implicating the LMW fraction's CD44 receptor interaction or epidermal penetration require more sophisticated study designs — ideally using confocal laser scanning microscopy or tape-stripping methodology to demonstrate differential penetration of labelled HA fractions — before they can be used in regulated markets without risk of challenge. The consultancy framing that characterises the global cosmetics industry's most successful multi-weight serum launches positions these actives under the overarching story of "multi-depth hydration" while ensuring that each layer of the mechanism is supported by robust, market-appropriate substantiation data.